Subgroup analyses of data from an open-label study of intravenous recombinant tissue plasminogen activator (rt-PA) administered to stroke patients were performed. Clinical outcome and incidence of intracranial hemorrhage were evaluated in 20 patients diagnosed by transcranial Doppler ultrasound as having proximal middle cerebral artery (MCA) occlusion. Additionally early infarct signs and size of final infarction were assessed. A favorable outcome (mRS 0–2) was seen in 30% of all patients. The incidence of symptomatic intracranial hematoma (10%) in patients with proximal MCA occlusion was higher than the overall hemorrhage rate of intravenous rt-PA treatment, but comparable to the data on intra-arterial thrombolysis in this stroke subgroup. All patients except 1 developed ischemic infarction in the MCA territory. Intravenous rt-PA treatment within 3 h may also be effective in patients with proximal MCA occlusion. The risk of intracerebral hematoma does not seem to be greater than in intra-arterial thrombolysis.

Keywords:
Thrombolysis, Middle cerebral artery occlusion, Stroke, acute
1.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator in acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
2.
Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M: PROACT: A phase II randomized trial of recombinant pro-urokinase by direct delivery in acute middle cerebral artery stroke. Stroke 1998;29:4–11.
3.
Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F, for the PROACT Investigators: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: A randomized controlled trial. JAMA 1999;282:2003–2011.
4.
Caplan LR, Mohr JP, Kistler JP, Kroshetz W: Thrombolysis – Not a panacea for ischemic stroke. N Engl J Med 1997;337:1309–1310.
5.
Easton D: Thrombolysis for stroke. Cerebrovasc Dis 1998;8:191–197.
6.
Grond M, Stenzel C, Schmülling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD: Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29:1544–1549.
7.
Von Kummer R, Meyding-Lamadé U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K: Sensitivity and prognostic value of early CT in occlusion of middle cerebral artery trunk. Am J Neurol Res 1994;15:9–15.
8.
Report of the American Academy of Neurology: Assessment: Transcranial Doppler. Neurology 1990;40:680–681.
9.
Hennerici M, Rautenberg W, Schwartz A: Transcranial Doppler ultrasound for the assessment of intracranial flow velocity. Part 2: Evaluation of intracranial arterial disease. Surg Neurol 1987;27:523–532.
10.
Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, and the NINDS TPA Stroke Study Group: Improved reliability of the NIH stroke scale using video training. Stroke 1994;25:2220–2226.
11.
Van Swieten JC, Koudstaal PJ, Visser M, Schouten HJA, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
12.
The NINDS rt-PA Stroke Study Group: Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109–2118.
13.
Boysen G: Overview in thrombolysis in acute ischemic stroke. Fibrinolysis 1995;9:29–32.
14.
Ueda S, Fujitsu K, Inomori S, Kuwabara T: Thrombotic occlusion of the middle cerebral artery. Stroke 1992;23:1761–1766.
15.
Yoshimoto T, Ogawa A, Seki H, Kogure T, Suzuki J: Clinical course of acute middle cerebral artery occlusion. J Neurosurg 1986;65:326–330.
16.
Saito I, Hiromu S, Shiokawa Y, Taniguchi M, Tsutsumi K: Middle cerebral artery occlusion: Correlation of computed tomography and angiography with clinical outcome. Stroke 1987;18:863–868.
17.
Bendszus M, Urbach H, Ries F, Solymosi L: Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 1998;40:54–58.
18.
von Kummer R, Bourquain H, Manelfe C, Bastianello S, Bozza L, Meier D: Predictive value of early CT in acute ischemic stroke (abstract). Stroke 1999;30:250.
19.
Grond M, von Kummer R, Sobesky J, Schmülling S, Heiss WD: Early computed-tomography abnormalities in acute stroke. Lancet 1997;350:1595–1596.
20.
Heiss WD, Grond M, Thiel A, von Stockhausen HM, Rudolf J: Ischemic brain tissue salvaged from infarction with alteplase. Lancet 1997;349:1599–1600.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.